# A Safety and Effective Study of Ginkgolides Diterpene Lactone Meglumine Injection in the Treatment of Ischemic Stroke.

Study · id `cardio:ct-nct02526225` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02526225](<https://clinicaltrials.gov/study/NCT02526225>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02526225

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3452 participants.

## Technical summary

Registry record NCT02526225. Randomized; triple masking; primary purpose treatment. Start 2016-02-01 (registry gives no type); primary completion 2018-05-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 3452 participants (enrolled count; ClinicalTrials.gov record NCT02526225, source copy `cardio:ctgov-nct02526225-2023-03-30`, retrieved 2026-10-26)
- Start date: 2016-02-01 (registry gives no type) (ClinicalTrials.gov record NCT02526225, source copy `cardio:ctgov-nct02526225-2023-03-30`, retrieved 2026-10-26)
- Primary completion: 2018-05-01 (actual) (ClinicalTrials.gov record NCT02526225, source copy `cardio:ctgov-nct02526225-2023-03-30`, retrieved 2026-10-26)
- Completion: 2019-08-31 (actual) (ClinicalTrials.gov record NCT02526225, source copy `cardio:ctgov-nct02526225-2023-03-30`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02526225, source copy `cardio:ctgov-nct02526225-2023-03-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02526225-2023-03-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Safety and Effective Study of Ginkgolides Diterpene Lactone Meglumine Injection in the Treatment of Ischemic Stroke.
- Condition: Ischemic Stroke
- Intervention (Drug): Ginkgo diterpene lactone meglumine injection
- Intervention (Drug): Ginkgo diterpene lactone meglumine injection simulation
- Lead sponsor: Beijing Tiantan Hospital
- Lead sponsor class: OTHER
- Collaborator: Beijing Bionovo Medicine Development Co., Ltd.
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy and Safety of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke: A Randomized Clinical Trial (`cardio:pubmed-37578791`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of ginkgo diterpene lactone meglumine on the quality of life in patients with acute ischemic stroke (`cardio:pubmed-39548582`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 2f8e84aa4d51415787b10b4986b73dcced51590698b87f9be6ecc2c548cd63e8
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
